EPO and anemia: The inflammatory response created by a subclinical or silent infection may lead to decreased responsiveness of bone marrow to erythropoietin mediated by inflammatory cytokines, specifically interleukin 1 (IL-1) and tumor necrosis factor alpha (TNF-α) and thus anemia [19–21].